Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 50.16M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -3.17M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -13.00% |
| Sales | 608.52k | PEG | - | EPS past 5Y | - | 200D Avg Chg | -37.00% |
| Dividend | N/A | Price/Book | 37.50 | EPS next 5Y | - | 52W High Chg | -73.00% |
| Recommedations | - | Quick Ratio | 1.75 | Shares Outstanding | 44.24M | 52W Low Chg | 71.00% |
| Insider Own | 59.30% | ROA | -80.41% | Shares Float | 18.01M | Beta | -615.27 |
| Inst Own | 4.95% | ROE | -196.34% | Shares Shorted/Prior | -/- | Price | 1.20 |
| Gross Margin | 79.28% | Profit Margin | - | Avg. Volume | 1,447 | Target Price | - |
| Oper. Margin | -330.99% | Earnings Date | May 16 | Volume | 2,500 | Change | 0.00% |
About NUO THERAPEUTICS INC
Nuo Therapeutics, Inc., a regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. Its technology separates autologous blood to produce a platelet based therapy for the chronic wound care market. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was incorporated in 1998 and is based in Houston, Texas.
NUO THERAPEUTICS INC News
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| SHEEDY CHARLES E | 10% Owner 10% Owner | Dec 19 | Buy | 0.50 | 150,000 | 75,000 | 11,212,500 | 12/20/23 |
| SHEEDY CHARLES E | 10% Owner 10% Owner | Aug 01 | Buy | 2 | 62,500 | 125,000 | 11,062,500 | 08/04/23 |
| JORDEN DAVID EMERSON | CEO/CFO CEO/CFO | Nov 09 | Sell | 1.5 | 162,500 | 243,750 | 1,975,358 | 11/14/22 |
| SHEEDY CHARLES E | 10% Owner 10% Owner | Apr 29 | Buy | 1 | 804,868 | 804,868 | 11,000,000 | 05/02/22 |